Transcranial Magnetic stimulation TMS was first approved by the US Food and Drug Administration in 2008 for the treatment of major depression.
• In 2010, Many clinical research and experience suggest that it may also be effective for anxiety.
—> Results showed a 60% response rate and a 60% remission rate
• rTMS therapy was also approved by Health Canada for clinical delivery in Canada
PROVEN & APPROVED by the FDA and HEALTH CANADA
Or by Phone —